Fuwei Yang

Changchun, 130033, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

In situ-formed multifunctional nanozyme hydrogel for synergistic radio-immunotherapy of osteosarcoma.

In situ-formed multifunctional nanozyme hydrogel for synergistic radio-immunotherapy of osteosarcoma.

Journal: Mikrochimica acta

Published: March 13, 2026

Corrigendum to "Synthesis and clinical application of new drugs approved by NMPA in 2023" [European Journal of Medicinal chemistry 283 (2025) 117181/EJMECH-d-24-03758].

Corrigendum to "Synthesis and clinical application of new drugs approved by NMPA in 2023" [European Journal of Medicinal chemistry 283 (2025) 117181/EJMECH-d-24-03758].

Journal: European journal of medicinal chemistry

Published: June 11, 2025

New FDA drug approvals for 2024: Synthesis and clinical application.

New FDA drug approvals for 2024: Synthesis and clinical application.

Journal: European journal of medicinal chemistry

Published: December 06, 2024

Synthesis and clinical application of new drugs approved by NMPA in 2023.

Synthesis and clinical application of new drugs approved by NMPA in 2023.

Journal: European journal of medicinal chemistry

Published: November 29, 2024

Clinical applications of small-molecule GABAAR modulators for neurological disorders.

Clinical applications of small-molecule GABAAR modulators for neurological disorders.

Journal: Bioorganic chemistry

Published: October 02, 2024

The evolution of small-molecule Akt inhibitors from hit to clinical candidate.

The evolution of small-molecule Akt inhibitors from hit to clinical candidate.

Journal: European journal of medicinal chemistry

Published: September 09, 2024

Discovery of novel XPO1 PROTAC degraders for the treatment of acute myeloid leukemia.

Discovery of novel XPO1 PROTAC degraders for the treatment of acute myeloid leukemia.

Journal: European journal of medicinal chemistry

Published: September 04, 2024

The journey of p38 MAP kinase inhibitors: From bench to bedside in treating inflammatory diseases.

The journey of p38 MAP kinase inhibitors: From bench to bedside in treating inflammatory diseases.

Journal: European journal of medicinal chemistry

Published: August 14, 2024

Enzyme-loaded glycogen nanoparticles with tumor-targeting Activatable host-guest supramolecule for augmented chemodynamic therapy.

Enzyme-loaded glycogen nanoparticles with tumor-targeting Activatable host-guest supramolecule for augmented chemodynamic therapy.

Journal: International journal of biological macromolecules

Published: May 17, 2022

Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies.

Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies.

Journal: Prostate cancer and prostatic diseases

Published: May 02, 2022

Bacteria-mediated cancer therapies: opportunities and challenges.

Bacteria-mediated cancer therapies: opportunities and challenges.

Journal: Biomaterials science

Published: July 27, 2021

Silencing hsa_circ_PVT1 (circPVT1) suppresses the growth and metastasis of glioblastoma multiforme cells by up-regulation of miR-199a-5p.

Silencing hsa_circ_PVT1 (circPVT1) suppresses the growth and metastasis of glioblastoma multiforme cells by up-regulation of miR-199a-5p.

Journal: Artificial cells, nanomedicine, and biotechnology

Published: December 24, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026